INTRODUCTION {#sec1-1}
============

Disulfides are the most common covalent interactions within a protein molecule involved in cross‐linking of sequentially distant residues. By bringing about entropic destabilization of the unfolded state, disulfides can confer stability on the protein.[1](#bib1){ref-type="ref"}, [2](#bib2){ref-type="ref"} Disulfide engineering is thus an important method of enhancing protein stability. Although the removal of a naturally‐occurring disulfide in a protein molecule results in destabilization, the introduction of a non‐naturally occurring disulfide bridge does not typically result in stabilization of the protein molecule.[3](#bib3){ref-type="ref"}, [4](#bib4){ref-type="ref"}, [5](#bib5){ref-type="ref"} This might be a consequence of the energetic penalty required for rearrangement of residues surrounding the cysteines to accommodate the disulfide, as well as due to loss of favorable interactions involving the original wild‐type (WT) residues.[2](#bib2){ref-type="ref"} Alternatively, the conformational characteristics of the disulfide formed might be energetically unfavorable. A study of cross‐strand disulfides in antiparallel β‐sheets had previously shown that while disulfides formed at the non‐hydrogen bonded registered pairs are stabilizing, those in the hydrogen bonded positions are destabilizing.[5](#bib5){ref-type="ref"}, [6](#bib6){ref-type="ref"} Hence, an understanding of disulfides in the context of protein structures could provide valuable information for protein engineering. Engineered disulfides can also act as conformational constraints and to validate protein models.[7](#bib7){ref-type="ref"} Hence, it is important to understand the conformational determinants of disulfides formed within and between different types of secondary structures.

Intrahelical disulfides are a characteristic feature of active sites of several oxidoreductases.[8](#bib8){ref-type="ref"}, [9](#bib9){ref-type="ref"} In addition to playing an important functional role, they also stabilize the protein.[3](#bib3){ref-type="ref"} The importance of the CXXC (CYS‐X‐X‐CYS tetrapeptide) motif at the N‐termini of helices in catalysis of redox reactions is well known.[10](#bib10){ref-type="ref"}, [11](#bib11){ref-type="ref"}, [12](#bib12){ref-type="ref"}, [13](#bib13){ref-type="ref"}, [14](#bib14){ref-type="ref"} This motif has been aptly described as a rheostat in the active site of oxidoreductases.[9](#bib9){ref-type="ref"} The motif can be highly reducing as in thioredoxin or highly oxidizing as in DsbA.[15](#bib15){ref-type="ref"}, [16](#bib16){ref-type="ref"}, [17](#bib17){ref-type="ref"} Altering the two XX residues alters the reduction potential of the disulfide. The redox potential variation and the change in activity of several oxidoreductases have been studied following mutation of the XX residues.[8](#bib8){ref-type="ref"}, [15](#bib15){ref-type="ref"}, [18](#bib18){ref-type="ref"}, [19](#bib19){ref-type="ref"}, [20](#bib20){ref-type="ref"}, [21](#bib21){ref-type="ref"}, [22](#bib22){ref-type="ref"} The CXXC motif in oxidoreductases has also been shown to play a role in conferring substrate specificity.[23](#bib23){ref-type="ref"} The CXXC motif is a characteristic feature of the thioredoxin fold. Minor variations in the fold structure and active site leads to a diverse collection of proteins with varying functions.[24](#bib24){ref-type="ref"} Homology searches for oxidoreductases carrying CXXC motifs has revealed the presence of proteins with CXXC derived sequences like CXXS, CXXT, TXXC, and SXXC. These CXXC derived sequences also occur at the N‐termini of helices and are believed to confer redox activity.[25](#bib25){ref-type="ref"}

A synthetic helical peptide containing CAAC at its N‐terminus was shown to form a disulfide with a redox potential of −230 mV and disulfide formation was shown to increase helicity in this peptide.[26](#bib26){ref-type="ref"} It is not known if introduction of CXXC motifs in protein helices that lack this motif can confer redox function. Other potential disulfide forming motifs such as CXC and CC have been introduced at or near helices to alter activity and engineer redox switches, respectively.[27](#bib27){ref-type="ref"}, [28](#bib28){ref-type="ref"} However, both CXC and CC motifs do not occur in disulfide bonded forms in naturally‐occurring protein helices.

In the present work, we have carried out a comprehensive analysis of the stereochemical characteristics of disulfides occurring within α‐helices. From the analysis of intrahelical disulfides in the Protein Data Bank (PDB), experimental studies on thioredoxin mutants and modeling studies, we attempt to understand requirements for disulfide formation with respect to positions and conformations of cysteines within an α‐helix.

All naturally‐occurring intrahelical disulfides occurred at N‐termini of helices with the N‐terminal CYS being the N‐Cap residue (See [methods](#sec1-2){ref-type="sec"} section for N‐Cap definition). Further, all naturally‐occurring intrahelical disulfides have two residues between the cysteines. These observations prompted us to engineer CXXC motifs at N‐termini as well as the interior of helices of *Escherichia coli* thioredoxin to ascertain the ability of different regions of helices to accommodate disulfide bridges. Spontaneous disulfide formation was observed only for mutants where the N‐terminal CYS was the N‐Cap residue. The effects of engineered helical disulfides on the stability and activity of the protein were determined.

 {#sec1-sidebar-1}

###### Abbreviations

CD, circular dichroism; CGH10, sodium citrate 10 m*M*, glycine 10 m*M*, HEPES 10 m*M*; DSC, differential scanning calorimetry; DTT, dithiothreitol; GdmCl, guanidinium chloride; MODIP, modeling of disulfide bridges in proteins; PDB, protein data bank; Trx, thioredoxin; UV, ultra‐violet; WT, wild type.

MATERIALS AND METHODS {#sec1-2}
=====================

Dataset generation {#sec2-1}
------------------

Using structures with resolution better than 2.0 Å and a sequence identity cutoff of 40%, a non‐redundant protein dataset of 5025 polypeptides with 2311 disulfides was generated for analysis. This protein dataset was used to identify helical segments.

Different criteria (such as hydrogen bonding patterns with and without torsional angle criteria) have been previously used to assign secondary structures in PDB records.[29](#bib29){ref-type="ref"}, [30](#bib30){ref-type="ref"} In the present study, to ensure internal consistency, we adopted a backbone torsion angle based method as previously mentioned by Ramakrishnan and Srinivasan[31](#bib31){ref-type="ref"} for identification of helices. The values of torsion angle ranges used for identifying helical residues were −120° to −10°, and −120° to 20° for ϕ and ψ, respectively. Stretches of consecutive, helical amino acids at least four residues long were identified as helices. The residues with non‐helical (ϕ, ψ) values immediately preceding the N‐terminus of a helix and succeeding the C‐terminus of a helix are referred to as the N‐Cap and C‐Cap residues, respectively.[32](#bib32){ref-type="ref"}, [33](#bib33){ref-type="ref"} A helical segment is defined as extending from the N‐Cap residue to C‐cap residue. Thus, a helical segment consists of an N‐Cap residue, a stretch of amino acids with helical (ϕ, ψ) values that is at least four residues long, and a C‐Cap residue. The numbering of all helical segments begins at 1 from the residue immediately following the N‐Cap residue. A dataset of 29,597 helical segments was obtained from our non‐redundant protein dataset.

Modeling of disulfides {#sec2-2}
----------------------

The program MODIP was used to model disulfides in helical segments.[34](#bib34){ref-type="ref"} The non‐glycine residue pairs that satisfy the MODIP criteria for *C* ^α^--*C* ^α^ (3.8 Å−7.0 Å) and *C* ^β^--*C* ^β^ (3.4 Å−4.5 Å) distances are chosen for geometrical fixation of sulfur atoms. Predicted disulfides are assigned a grade ranging from A--C based on the S‐S bond length and dihedral angles of the modeled cystines. The various criteria that the software MODIP uses have been described previously.[34](#bib34){ref-type="ref"}, [35](#bib35){ref-type="ref"}

*In silico* mutation and energy minimization studies {#sec2-3}
----------------------------------------------------

As an alternative to MODIP, the program Swiss‐PDB Viewer[36](#bib36){ref-type="ref"} was used to model CYS mutations *in silico* following which energy minimizations were carried out in vacuum using the l‐bfgs minimizer and OPLS‐AA/L force field in the GROMACS 3.3.3 package.[37](#bib37){ref-type="ref"}

Experimental materials {#sec2-4}
----------------------

Enzymes and reagents for mutagenesis were obtained from New England BioLabs. Q‐Sepharose resin and NAP‐10 columns were purchased from GE Healthcare. Dithiothreitol (DTT) and Guanidinium chloride (GdmCl) (MB grade) were purchased from USB chemicals. All other reagents used in protein purification and characterization were obtained from Sigma.

Mutagenesis {#sec2-5}
-----------

The WT thioredoxin (Trx) gene was cloned into the pET20b vector as described previously.[38](#bib38){ref-type="ref"} Both active site cysteines in WT Trx were mutated to serines. This latter thioredoxin construct is henceforth referred to as nSS Trx. All other mutants were made in the nSS Trx background. CXXC motifs were introduced in helices of nSS Trx by site directed mutagenesis. There were three kinds of mutants generated; N‐CapC‐3C, 1C‐4C, and 7C‐10C where the numbers denote the position of the indicated residue in the helix. Residue numbering in helices is as defined in the [dataset generation](#sec2-1){ref-type="sec"} section. All mutants were generated by site directed mutagenesis following the Stratagene QuikChange protocol as described previously.[39](#bib39){ref-type="ref"} The mutants generated in this work are listed in Table [I](#tbl1){ref-type="table"}.

###### 

Description of nSS Trx Mutants

  WT Trx sequence[a](#fn1){ref-type="fn"}   CX~1~X~2~C mutant[b](#fn2){ref-type="fn"}   Position of CX~1~X~2~C in the helix[c](#fn3){ref-type="fn"}
  ----------------------------------------- ------------------------------------------- -------------------------------------------------------------
  NIDQ (59--62)                             CIPC                                        N‐Cap‐3
  NIDQ (59--62)                             CIDC                                        N‐Cap‐3
  NIDQ (59--62)                             CGPC                                        N‐Cap‐3
  SKGQ (95--98)                             CKGC                                        N‐Cap‐3
  SKGQ (95--98)                             CGPC                                        N‐Cap‐3
  IDQN (60--63)                             CDQC                                        1--4
  KGQL (96--99)                             CGQC                                        1--4
  FLDA (102--105)                           CLDC                                        7--10

Sequence before mutation in nSS Trx. The numbers in parentheses are the residue numbers of the two residues mutated to cysteines.

The identities of residues X~1~,X~2~ between the introduced cysteines are shown.

N‐Cap is the first residue of the relevant helix as defined in PDB records. The residue immediately C‐terminal to N‐Cap in the helix is residue 1.
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Expression and purification of nSS Trx mutants {#sec2-6}
----------------------------------------------

All mutants were transformed into *E. coli* BL21 (DE3) cells and expressed under control of the T7 promoter at 37°C. Cells were harvested by centrifugation, subjected to chloroform shock, and purified by anion exchange chromatography as described previously.[38](#bib38){ref-type="ref"} The purified proteins were \>95% pure as assayed by SDS‐PAGE. Protein concentrations were estimated by absorbance measurements at 280 nm in a Jasco V‐530 spectrophotometer. The extinction coefficients calculated from protein sequences[40](#bib40){ref-type="ref"} for nSS Trx and its disulfide containing mutants are 13,980*M* ^−1^ cm^−1^ and 14,105*M* ^−1^ cm^−1^, respectively

Iodoacetamide labeling of free CYS residues followed by ESI‐MS {#sec2-7}
--------------------------------------------------------------

Thirty micromolar protein was treated with 100 m*M* iodoacetamide in the presence of 100 m*M* Tris, 3*M* GdmCl, pH 8.0 for 4 min at room temperature.[41](#bib41){ref-type="ref"} The labeling reaction was quenched with 5% formic acid. All samples were desalted using NAP‐10 columns into 0.1% formic acid for mass spectrometry. The desalted samples were analyzed by direct injection on a Bruker Daltonics Esquire 3000 plus electrospray ionization mass spectrometer in positive ion mode to determine whether the CYS residues were in the oxidized or reduced state and whether disulfides were intramolecular or intermolecular. Protein samples without the iodoacetamide treatment served as the control.

*In vitro* oxidation of protein {#sec2-8}
-------------------------------

To facilitate the oxidation of cysteines in certain mutants, each of the proteins (80--100 μ*M*) was incubated with 5 m*M* 1,10‐phenanthroline monohydrate and 1.5 m*M* copper sulfate in 100 m*M* Tris buffer (pH 8.0) at 20°C for 24 h.[42](#bib42){ref-type="ref"} Following oxidation, 10 mL of the protein was dialyzed against 1 L of 10 m*M* Sodium citrate, 10 m*M* Glycine, 10 m*M* HEPES (CGH 10) buffer, pH 7.0 at 4°C with 4 buffer changes at 4 h intervals.

Circular dichroism {#sec2-9}
------------------

The instrument was calibrated with D‐10‐camphor sulfonic acid as described.[43](#bib43){ref-type="ref"} Far UV CD spectra were collected for all the mutants on a Jasco715 spectropolarimeter flushed with nitrogen gas at 25°C. A cuvette of path length 1 mm was used and four scans were averaged to obtain the spectrum for each protein. CD spectra from 200--250 nm were acquired using 50 nm min^−1^ scan rate, 0.5 s response time, 1 nm bandwidth, and 2 nm data pitch. The proteins were in CGH 10 buffer, pH 7.0. For proteins in the reduced state, the buffer included 1 m*M* DTT in addition to the components mentioned above. The concentration of each protein was 10 μ*M*. Spectra were corrected for buffer contributions by subtraction of corresponding buffer spectra collected under identical conditions.

Chemical denaturation studies {#sec2-10}
-----------------------------

Stability studies were carried out by monitoring the CD signal at 220 nm in a Jasco J‐715 CD spectropolarimeter for 10 μ*M* protein in different concentrations of GdmCl in the buffer CGH10 at 25°C. For denaturation profiles of reduced proteins, the samples included 1m*M* DTT in addition to the components mentioned above. Denaturant concentrations were ascertained by refractive index measurements using an Abbe refractometer (Techno Instruments and Chemicals). Prior to measurement of CD signals, the samples were incubated with denaturant for 3 h at 25°C. The data obtained was fit to a two state denaturation profile to obtain the various thermodynamic parameters as described previously.[44](#bib44){ref-type="ref"}

Thermal denaturation studies {#sec2-11}
----------------------------

Differential scanning calorimetry (DSC) was performed using a VP‐DSC instrument (Microcal) to ascertain the thermal stability of the proteins. A scan rate of 60°C h^−1^ was used. The concentration of each protein used was 25 μ*M* in CGH10 buffer, pH 7.0. Two scans were performed in succession to determine the reversibility of the transitions. The data was fit to a two state transition using Origin software to obtain thermodynamic parameters as described previously.[38](#bib38){ref-type="ref"}, [45](#bib45){ref-type="ref"}, [46](#bib46){ref-type="ref"}

Insulin reduction assay[47](#bib47){ref-type="ref"} {#sec2-12}
---------------------------------------------------

All experiments were carried out at 25°C in a Jasco V‐530 spectrophotometer using a 1 cm path length cuvette. Each assay mixture contained 0.1*M* phosphate buffer (pH 7.0), 2 m*M* EDTA, 0.13 m*M* porcine insulin, 0.33 m*M* DTT, and 10 μ*M* of the protein to be studied. Following DTT addition, the formation of insoluble insulin B‐chain aggregates was monitored by measurement of the intensity of scattered light at 650 nm as a function of time. As control experiments, the activity of WT Trx, nSS Trx, MBP230C 30C, and Trx20C 73C were monitored.

RESULTS AND DISCUSSION {#sec1-3}
======================

Location of intrahelical disulfides and CXXC motifs {#sec2-13}
---------------------------------------------------

Using the helix definitions described in the [methods](#sec1-2){ref-type="sec"} section and disulfide identification by using SSBOND records in the PDB files, the non‐redundant dataset was examined for intrahelical disulfides. Thirty‐five instances of intrahelical disulfides were found. All 35 naturally‐occurring intrahelical disulfides were found between N‐Cap and third residue of helices. Naturally‐occurring intrahelical disulfides exclusively occur as a CXXC motif. The requirement for a CXXC motif is indicative of the optimal proximity that the CYS side chains can achieve in a helix for the formation of disulfide when the loop length is two. In this situation, both residues are on the same face of the helix, given that an α‐helix typically has 3.6 residues per turn.

The occurrence of all intrahelical disulfides in CXXC motifs led us to search for CXXC motifs in the protein dataset. Examination of the non‐redundant protein dataset identified 642 CXXC motifs. Of these, 102 motifs occur at the N‐termini of the helices such that the N‐terminal CYS is the N‐Cap residue. As mentioned earlier in this section, 35 of these 102 CXXC motifs are disulfide bonded (Table [II](#tbl2){ref-type="table"}, [48](#bib48){ref-type="ref"}) and the remaining 67 are in the reduced state. Of the 35, 24 disulfides occurred in oxidoreductases and one is involved in metal ion transfer. For the remaining 10 instances, the disulfide does not appear to have a role in the function of the protein.

###### 

Proteins with Intrahelical Disulfides from a Non‐Redundant Dataset of 5025 Polypeptides

  PDB ID                         Chain ID   N‐term CYS   C‐term CYS   CX~1~X~2~C   Function of protein                                              Scop FOLD[a](#fn4){ref-type="fn"}
  ------------------------------ ---------- ------------ ------------ ------------ ---------------------------------------------------------------- -----------------------------------
  1a8l[b](#fn5){ref-type="fn"}              146          149          CPYC         Protein disulfide oxidoreductase from *A. pyrococcus*            Thioredoxin like
  1a8l[b](#fn5){ref-type="fn"}              35           38           CQYC         Protein disulfide oxidoreductase from *A. pyrococcus*            Thioredoxin like
  1aba[b](#fn5){ref-type="fn"}              14           17           CGPC         Bacteriophage T4 glutaredoxin                                    Thioredoxin like
  1eej[b](#fn5){ref-type="fn"}   A          98           101          CGYC         *E. coli* DsbC                                                   Thioredoxin like
  1faa[b](#fn5){ref-type="fn"}   A          46           49           CGPC         Thioredoxin F from spinach chloroplast                           Thioredoxin like
  1fl2[b](#fn5){ref-type="fn"}   A          345          348          CPHC         *E. coli* alkylhydroperoxide reductase                           FAD/NAD(P)‐binding domain
  1gai                                      210          213          CSWC         *A. awamori* glucoamylase‐471 with D‐gluco‐dihydroacarbose       Alpha/Alpha Toroid
  1goi                           A          328          331          CEEC         *S. marcescens* chitinase B D140N mutant                         WW‐domain like
  1h75[b](#fn5){ref-type="fn"}   A          11           14           CVQC         Glutaredoxin like protein from *E. coli*                         Thioredoxin like
  1jfu[b](#fn5){ref-type="fn"}   A          72           75           CVPC         Thiol disulfide interchange protein from *B. japonicum*          Thioredoxin like
  1jr8[b](#fn5){ref-type="fn"}   A          54           57           CGEC         Sulfhydryl oxidase from *S. cerevisiae*                          Four‐helical up‐and‐down bundle
  1kng[b](#fn5){ref-type="fn"}   A          92           95           CVPC         Thioredoxin like protein from *B. japonicum*                     Thioredoxin like
  1lsh                           A          198          201          CPTC         Lipovitellin from silver lamprey                                 Alpha‐alpha superhelix
  1oqc                           A          62           65           CEEC         FAD dependent sulfhydryl oxidase from *R. norvegicus*            Four‐helical up‐and‐down bundle
  1osd[c](#fn6){ref-type="fn"}   A          14           17           CSAC         Hypothetical protein from *R. metallidurans*                     Ferredoxin‐like
  1qnr                           A          26           29           CYWC         Mannanase from *T. reesei*                                       TIM beta/alpha‐barrel
  1r26[b](#fn5){ref-type="fn"}   A          30           33           CGPC         Thioredoxin from *T. brucei*                                     Thioredoxin like
  1sen[b](#fn5){ref-type="fn"}   A          66           69           CGAC         Human thioredoxin like protein                                   Thioredoxin like
  1thx[b](#fn5){ref-type="fn"}              32           35           CGPC         Thioredoxin from *Anabena*                                       Thioredoxin like
  1v58[b](#fn5){ref-type="fn"}   A          109          112          CPYC         *E. coli* DsbG                                                   Thioredoxin like
  1v98[b](#fn5){ref-type="fn"}   A          62           65           CGPC         Thioredoxin from *T. thermophilus*                               No SCOP entry
  1vke                           A          59           62           CDDC         Carboxymuconolactone decarboxylase from *T. maritima*            AhpD‐like
  1w4v[b](#fn5){ref-type="fn"}   A          31           34           CGPC         Human thioredoxin                                                No SCOP entry
  1wou[b](#fn5){ref-type="fn"}   A          43           46           CPDC         Thioredoxin related protein from human                           Thioredoxin like
  1z3e[b](#fn5){ref-type="fn"}   A          10           13           CTSC         Transcription regulator from *B. subtilis*                       Thioredoxin like
  2a40                           A          101          104          CESC         Actin from rabbit in a ternary complex                           Ribonuclease H‐like motif
  2axo[b](#fn5){ref-type="fn"}   A          54           57           CASC         Hypothetical protein from *A. tumifaciens*                       Thioredoxin like
  2b1k[b](#fn5){ref-type="fn"}   A          80           83           CPTC         DsbE from *E.coli*                                               No SCOP entry
  2b94                           A          68           71           CAIC         Purine nucleoside phosphorylase homologue from *P. falciparum*   No SCOP entry
  2f51[b](#fn5){ref-type="fn"}   A          35           38           CGPC         *T. vaginalis* thioredoxin                                       No SCOP entry
  2f9s[b](#fn5){ref-type="fn"}   A          74           77           CEPC         *B. subtilis* thiol‐disulfide oxidoreductase resA                Thioredoxin like
  2fx5                           A          243          246          CSLC         *P. mendocina* lipase                                            No SCOP entry
  2i4a[b](#fn5){ref-type="fn"}   A          32           35           CGPC         Thioredoxin from *A. aceti*                                      No SCOP entry
  2j23[b](#fn5){ref-type="fn"}   A          30           33           CGPC         Thioredoxin from *M. sympodialis*                                No SCOP entry
  2ouw                           A          83           86           CSYC         Alkylhydroperoxidase from *R. rubrum*                            No SCOP entry

The folds for the protein cited are as mentioned in the SCOP database.[48](#bib48){ref-type="ref"}

Proteins that either have the thioredoxin fold or function as oxidoreductases. In these cases (24 in number), the disulfide is directly implicated in protein function.

CXXC motif is believed to play a role in metal ion transfer.
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There are 67 instances of CXXC motifs between N‐Cap and third residue with both CYS residues in the reduced state. Of these 67, the cysteines in 45 of them are involved in coordination of metal ions. In addition to the 45 metal coordinating proteins, there are four cytochromes where the heme moiety is coordinated by the cysteines. Nine proteins have redox function indicating that their CXXC motifs can also exist in the oxidized state. In the protein PLP synthase from *P. falciparum* (PDB ID: 2abw), the N‐terminal CYS was part of the active site of the protein. For the remaining cases, the function of the proteins cannot be attributed to the cysteine oxidation state. A set of 20 proteins (out of the 67 described above) with nonbridged CXXC motifs are tabulated in Table [III](#tbl3){ref-type="table"}.[48](#bib48){ref-type="ref"} These 20 cases were predicted by MODIP as potential disulfide introduction sites. The program MODIP predicts residue locations in a protein that are stereochemically compatible with disulfide formation.[34](#bib34){ref-type="ref"}, [35](#bib35){ref-type="ref"}

###### 

Proteins with a MODIP Predicted, Non‐Disulfide Bonded Intrahelical CX~1~X~2~C Motif from a Non‐Redundant Dataset of 5025 Polypeptides

  PDB ID                         Chain ID   N‐term CYS   C‐term CYS   CX~1~X~2~C   Function of protein                                                        Fold(SCOP)[a](#fn7){ref-type="fn"}
  ------------------------------ ---------- ------------ ------------ ------------ -------------------------------------------------------------------------- ------------------------------------
  1erv[b](#fn8){ref-type="fn"}              32           35           CGPC         Human thioredoxin mutant                                                   Thioredoxin like
  1lu4[b](#fn8){ref-type="fn"}   A          1036         1039         CPFC         Alkylperoxidase from *M. tuberculosis*                                     Thioredoxin like
  1svm                           A          302          305          CLKC         SV40 large T antigen helicase                                              P‐loop containing nucleoside
  Triphosphate hydrolases                                                                                                                                     
  1z6m[b](#fn8){ref-type="fn"}   A          36           39           CPYC         Protein of unknown function from *E. faecalis*                             Thioredoxin like
  1z6n[b](#fn8){ref-type="fn"}   A          66           69           CPDC         Protein of unknown function from *P. aeroginosa*                           Thioredoxin like
  1z84[c](#fn9){ref-type="fn"}   A          216          219          CCLC         Galactose‐1‐phosphate uridyl transferase like protein from *A. thaliana*   HIT‐lke
  1zma[b](#fn8){ref-type="fn"}   A          38           41           CPYC         Bacterocin transport accessory protein from *S. pneumoniae*                Thioredoxin like
  2a1k[c](#fn9){ref-type="fn"}   A          87           90           CPYC         ssDNA binding protein core domain from *Enterobacter* phage RB69           No SCOP entry
  2ckl[c](#fn9){ref-type="fn"}   A          39           42           CKTC         Polycomb complex protein BMI1 from *M. musculus*                           No SCOP entry
  2ckl[c](#fn9){ref-type="fn"}   B          72           75           CADC         Polycomb complex protein BMI1 from *M. musculus*                           No SCOP entry
  2fb6                           A          74           77           CQDC         Protein of unknown function from *B. thetaiotaomicron*                     No SCOP entry
  2fwh[b](#fn8){ref-type="fn"}   A          461          464          CVAC         C‐terminal domain of DsbD from *E. coli*                                   Thioredoxin like
  2fyg[c](#fn9){ref-type="fn"}   A          74           77           CLYC         NSP10 from SARS coronavirus                                                Coronavirus NSP10‐like
  2gmy                           A          48           51           CAFC         Polycomb comples protein *A. tumifaciens*                                  AhpD‐like
  2h30[b](#fn8){ref-type="fn"}   A          68           71           CPLC         Peptide methionine sulfoxide reductase from *N. gonorrhoeae*               No SCOP entry
  2ht9[b](#fn8){ref-type="fn"}   A          37           40           CSYC         Human glutaredoxin                                                         No SCOP entry
  2nll[c](#fn9){ref-type="fn"}   B          357          360          CQEC         Thyroid hormone receptor from human                                        Glucocorticoid receptor‐like
  2o4d                           A          48           51           CAYC         Hypothetical protein from *P. aeruginosa*                                  AhpD‐like
  2oik[c](#fn9){ref-type="fn"}   A          11           14           CELC         Histidine triad protein from *M. flagellatus*                              No SCOP entry
  4mt2[c](#fn9){ref-type="fn"}              41           44           CSQC         Metallothienin from *R. novewrgicus*                                       Metallothienin

The folds for the protein cited are as mentioned in the SCOP database.[48](#bib48){ref-type="ref"}

Proteins that either have the thioredoxin fold or function as oxidoreductases.

Proteins where Zn^2+^ ion is coordinated through the CYS residues in CX~1~X~2~C.
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The above observations and conclusions were based on specific dihedral angle based criteria to identify helical segments. An alternate method of identifying helical segments is to use the HELIX records in the header of each PDB file. A comparison of the helical segments carrying N‐terminal helical CXXC motifs (N‐terminal CYS of CXXC is the N‐Cap of helix) defined by us with the corresponding helical segments defined using PDB records was done (Table SI, Supporting information). In 76 out of 102 instances, N‐Cap defined by us coincides with the first residue of the helix in PDB records. There were 17, 4, and 3 instances found, where the first residue of the helix in the PDB records is the first, second, and third residue of helix, respectively, as defined in this article. In the remaining four cases, none of the residues that are part of the N‐terminal helical CXXC motif identified using our torsional angle criteria are part of helices defined in the PDB records. This analysis suggests that defining helical segments through our torsional angle criteria is preferable to using the PDB helix records for the purposes of the present study.

There are 115 instances of CXXC motifs occurring within a helix such that all four residues have a helical conformation. There are 17 cases of a CXXC motif occurring at the C‐termini of helices such that the C‐terminal CYS is the C‐Cap residue. However, none of them showed the presence of an intrahelical disulfide. There are a total of 408 instances of CXXC motifs in non‐helical positions. Of these 408 cases, only 14 of them showed the presence of a disulfide. Thus, CXXC motifs in regions other than N‐terminal helical positions have a very low tendency to form disulfides. None of the above disulfide containing 14 proteins show redox activity (Table [IV](#tbl4){ref-type="table"}, [48](#bib48){ref-type="ref"}). Only one of them (PDB ID: 2cog) shows a variation in activity depending on the oxidation state of the cysteines.

###### 

Proteins with Non‐Helical Disulfide Bonded CX~1~X~2~C from a Non‐Redundant Dataset of 5025 Polypeptides

  PDB ID   Chain ID   N‐term CYS   C‐term CYS   CX~1~X~2~C   Function of protein                                  Fold(SCOP)[a](#fn10){ref-type="fn"}
  -------- ---------- ------------ ------------ ------------ ---------------------------------------------------- -----------------------------------------
  2cog     A          335          338          CTGC         Human transferase                                    No SCOP entry
  1d7c     A          121          124          CQGC         *P. chrysosporium* B‐typ*e cytochrome*               Immunoglobulin‐like beta‐sandwich
  1kuf     A          162          165          CDTC         *P. mucrosquamatus* hydrolase                        Zincin‐like
  1qnr     A          172          175          CNGC         *T. reesei* hydrolase                                TIM beta/alpha‐barrel
  2hl7     A          25           28           CPKC         *P. aeruginosa* C‐type cytochrome                    No SCOP entry
  1k5c     A          300          303          CGNC         *C. purpureum* hydrolase                             Single‐stranded right‐handed beta‐helix
  1mp8     A          456          459          CKNC         Human tyrosine protein kinase                        Protein kinase‐like (PK‐like)
  1dl2     A          468          471          CVDC         *S. cerevisiae* hydrolase                            Alpha/Alpha Toroid
  1m6y     A          46           49           CPGC         *T. maritima* SAM‐dependent Methyltransferase Fold   SAM domain‐like
  1k3i     A          515          518          CGDC         *Fusarium* oxidoreductase                            Immunoglobulin‐like beta‐sandwich
  1rki     A          80           83           CDKC         *P. aerophilum* protein of unknown function          THUMP domain
  1tib     A          104          107          CSGC         *T. lamiginoosus* carboxylic esterase                α/β hydrolase
  1gof     A          515          518          CGDC         *H. rosellus* galactose oxidase                      Immunoglobin like β‐sanddwich
  2apr     A          48           51           CTNC         *R. chinesis* acid protease                          Acid protease

The folds for the protein cited are as mentioned in the SCOP database.[48](#bib48){ref-type="ref"}
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Residue identitites and main chain conformational preferences in intrahelical CXXC motifs {#sec2-14}
-----------------------------------------------------------------------------------------

Figure [1](#fig1){ref-type="fig"} represents the distribution of residues occurring between the cysteines in intrahelical CXXC motifs. As is evident from the histograms, the most commonly occurring motif is CGPC. This is due to the presence of a large number of thioredoxin family members, which have this sequence as a characteristic feature. The most preferred residues at positions 2 and 3 of the motif are glycine and proline, both of which occur at frequencies of ∼35%. However, other residues also occur between the cysteines.

![Residue preferences in the loop between the CYS residues in the intrahelical disulfide bonded CXXC motifs ('i' is the N‐terminal cysteine).](PROT-78-1228-g006){#fig1}

The backbone torsion angles ϕ, ψ, and ω were examined for all residues in intrahelical CXXC motifs. With the exception of the N‐terminal CYS, the other three residues had conformational preferences characteristic of a right‐handed α‐helix. The three residues following the N‐Cap CYS involved in disulfide bonded intrahelical CXXC motifs have mean (ϕ, ψ) values of (−58 ± 6.0°, −45 ± 9.5°), (−69 ± 15.5°, −27 ± 15.2°), and (−64 ± 7.2°, −40 ± 6.8°), respectively. The N‐Cap CYS had ϕ and ψ angles corresponding to a non‐helical conformation \[mean ϕ and ψ values of (−112 ± 25.2°, 106 ± 25.4°), respectively\] (see Fig. [2](#fig2){ref-type="fig"}). The obligatory requirement for the N‐terminal CYS residue to be non‐helical explains the occurrence of intrahelical disulfides exclusively at N‐termini. The ω angle (dihedral angle involving the amide bond) analysis revealed that there were no cis peptides present in intrahelical disulfide bonded CXXC motifs, despite the frequent occurrence of proline in these sequences.

![Ramachandran plots for the helix N‐Cap residues. **A**: (ϕ, ψ) Values for N‐Cap CYS in all intrahelical CXXC motifs predicted by MODIP to form disulfides. **B**: Subset of A which actually form disulfides. **C**: Subset of A which do not form disulfides. **D**: All N‐Cap residues in dataset predicted by MODIP to be a potential site for an intrahelical disulfide. **E**: (ϕ, ψ) Values for N‐Cap residues predicted by MODIP not to form a disulfide.](PROT-78-1228-g002){#fig2}

Side chain conformational preferences of disulfide bonded CXXC motifs {#sec2-15}
---------------------------------------------------------------------

A schematic description of side chain torsion angles in a disulfide bond is indicated in Figure [3](#fig3){ref-type="fig"}(A) and the distribution of torsion angles is shown in Figure [3](#fig3){ref-type="fig"}(B--D). The overall distribution of χss for all categories of disulfides shows two peaks at +90° and −90° \[Fig. [3](#fig3){ref-type="fig"}(B)\]. In contrast, χss of intrahelical disulfides is distributed exclusively around +90°.

![Disulfide torsion angles and their distributions. **A**: Torsion angle definitions. **B**--**D**: Circular histograms showing the percentage distributions for CYS side chain torsion angles for (B) all naturally‐occurring disulfides. C,D: Naturally‐occurring intrahelical disulfides. The percentage values for various angle ranges are indicated on the circumference of the histograms.](PROT-78-1228-g003){#fig3}

The intrahelical disulfide bonded N‐terminal CYS shows a distribution for χ~1~ and χ~2~ very different from that seen for other disulfide bonded cysteines \[compare Fig. [3](#fig3){ref-type="fig"}(C) with 3(B)\]. In addition, there are marked differences between χ$\,_{\text{i}}^{\text{1}}$ and χ$\,_{\text{j}}^{\text{1}}$ as well as χ$\,_{\text{i}}^{\text{2}}$ and χ$\,_{\text{i}}^{\text{2}}$ where i and j are the N and C terminal CYS residues involved in the disulfide bond \[compare Fig. [3](#fig3){ref-type="fig"}(C) with 3(D)\].

Lack of conformational change upon reduction of naturally‐occurring intrahelical disulfides {#sec2-16}
-------------------------------------------------------------------------------------------

To identify intrahelical disulfide containing proteins with structures available in both the oxidized and reduced state, each of the proteins from Tables [II](#tbl2){ref-type="table"} and [III](#tbl3){ref-type="table"} were queried against the PDB database for structures with sequence identities ≥95% and differing in cysteine oxidation state. Five such proteins belonging to the thioredoxin fold were identified. The *C* ^α^ RMSD values between the members of each pair of structures were less than 1 Å. A comparison of main chain torsion angles, (ϕ, ψ) for residues in the helix that carries the CXXC motif revealed very small differences between the two helices indicating that the N‐terminal intrahelical disulfide can be accommodated without introducing any drastic changes in the structure (Table [V](#tbl5){ref-type="table"}).

###### 

Differences in Torsion Angles of CX~1~X~2~C Residues in the Oxidized and Reduced Forms

  PDB ID Oxidized/ Reduced   Residue No.[a](#fn11){ref-type="fn"}   Residue   Difference in torsion angle[b](#fn12){ref-type="fn"}           
  -------------------------- -------------------------------------- --------- ------------------------------------------------------ ------- -------
  1eej/1tjd                  98                                     CYS       −19.1                                                  −6.4    −19.2
  1eej/1tjd                  99                                     GLY       4.6                                                    −3.2    --
  1eej/1tjd                  100                                    TYR       5.4                                                    −8.4    −0.6
  1eej/1tjd                  101                                    CYS       3.3                                                    −2.5    15.5
  1fvk/1a2l                  30                                     CYS       −12.2                                                  −11.6   153.7
  1fvk/1a2l                  31                                     PRO       6.7                                                    −1.2    −1.1
  1fvk/1a2l                  32                                     HIS       −11.7                                                  18.4    −21.9
  1fvk/1a2l                  33                                     CYS       −8                                                     −4.1    34.3
  1w4v/1w89                  31                                     CYS       12.4                                                   −3.1    21.7
  1w4v/1w89                  32                                     GLY       −20.3                                                  12.4    --
  1w4v/1w89                  33                                     PRO       −0.3                                                   −10     2.2
  1w4v/1w89                  34                                     CYS       4.9                                                    3.5     2.2
  2fwg/2fwh                  461                                    CYS       −4.4                                                   −2.4    9.4
  2fwg/2fwh                  462                                    VAL       −2                                                     −3.9    92.6
  2fwg/2fwh                  463                                    ALA       −3.9                                                   5       --
  2fwg/2fwh                  464                                    CYS       −1.5                                                   0       −0.4
  1eru/1erv                  32                                     CYS       −11.6                                                  −14.6   5.7
  1eru/1erv                  33                                     GLY       −19                                                    10.4    --
  1eru/1erv                  34                                     PRO       5.8                                                    −7.4    −11.0
  1eru/1erv                  35                                     CYS       −0.3                                                   5.9     16.4

Residue numbering for the CX~1~X~2~C motifs of the two proteins in each pair is the same. In all cases, the chain ID is "A."

Δ(Torsion angle) = (Torsion angle)~oxidized~−(Torsion angle)~reduced~.
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MODIP modeled intrahelical disulfides {#sec2-17}
-------------------------------------

MODIP is a program that identifies sites for disulfide introduction based on stereochemical criteria.[34](#bib34){ref-type="ref"}, [35](#bib35){ref-type="ref"} A database of 29,597 helical segments was created from the non‐redundant dataset as described in the [methods](#sec1-2){ref-type="sec"} section.[31](#bib31){ref-type="ref"} MODIP was used to identify potential sites for introduction of disulfide forming CYS residues in the helical segments (Table [VI](#tbl6){ref-type="table"}). Depending on the geometry of the modeled disulfide, the predicted sites are graded as A, B, and C by MODIP in descending order of stereochemical quality. Consistent with observations of naturally‐occurring intrahelical disulfides, all sites identified by MODIP also required the N‐terminal residue of the predicted site to have a non‐helical conformation. This residue was the N‐Cap of the helical segment. The number of residues (loop length) between the two potential cysteines varied from 0--4 with the maximum number of sites identified for a loop length of two. Although there are no A grade disulfides when loop length is zero, there are predicted disulfides with A grade for other loop lengths of 1--4. The above findings are consistent with those for naturally‐occurring disulfides. Disulfide formation is not possible in the interior or towards the C‐terminus of a helix because the *C* ^β^--*C* ^β^ distances between residues are incompatible with disulfide formation. The average *C* ^β^--*C* ^β^ distance for residues i and i+3 within a helix is 5.87 ± 0.55 Å. The favored *C* ^β^--*C* ^β^ distance for disulfide formation is in the range of 3.4 Å--4.6 Å.[34](#bib34){ref-type="ref"}, [35](#bib35){ref-type="ref"} These results indicate that only the residues at the N‐Cap positions of helices have the required stereochemistry to allow intrahelical disulfide formation.

###### 

MODIP Predicted Intrahelical Disulfide Sites in Non‐Redundant Dataset

  Residue position within helix[a](#fn13){ref-type="fn"}   Grade[b](#fn14){ref-type="fn"}                        
  -------------------------------------------------------- -------------------------------- ------ ------ ------ ------
  N‐Cap                                                    1                                16     0      0      16
  N‐Cap                                                    2                                1523   234    168    1121
  N‐Cap                                                    3                                9232   2398   2218   4616
  N‐Cap                                                    4                                162    33     44     85
  N‐Cap                                                    5                                7      2      0      5

The helix is numbered such that residue 1 is the first residue with helical ϕ, ψ and N‐Cap is immediately N‐terminal to residue 1.

Stereochemical grade of modeled disulfide assigned by MODIP.[34](#bib34){ref-type="ref"}, [35](#bib35){ref-type="ref"}
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If appropriate backbone torsion angles were the necessary and sufficient conditions for intrahelical disulfide formation, then the non‐helical N‐Cap of every helix may be a potential site for disulfide introduction depending on the extent of backbone conformational rearrangement that is possible. Since MODIP requires the position of the *C* ^β^ atom for modeling cystines, only non‐glycine residues are considered for disulfide introduction. Of the 20,157 helical segments with non‐glycine residues at N‐Cap and third position, MODIP predicted a disulfide linkage between the N‐Cap and third residues of the helical segments for 8779 cases. Helical segments where MODIP failed to predict a disulfide between residues N‐Cap and 3 are hereafter referred to as non‐MODIP predicted cases. The average (ϕ,ψ) values for the N‐Cap residue for MODIP predicted and non‐MODIP predicted cases are (−95 ± 31.6°, 118 ± 38.6°) and (−108 + 47°, 154 ± 59.3°), respectively. A comparison of the ϕ--ψ plot for the N‐Cap modeled CYS reveals a greater spread of values for non‐MODIP predicted cases relative to MODIP predicted cases (see Fig. [2](#fig2){ref-type="fig"}). The cases that were not predicted could be owing to MODIP\'s modeling of a disulfide on a rigid protein molecule. Hence, energy minimizations were carried out for the *in silico* introduced disulfides for a small subset of the MODIP predicted and non‐MODIP predicted cases.

Energy minimization for structures with introduced intrahelical disulfides {#sec2-18}
--------------------------------------------------------------------------

Using GROMACS 3.3.3, energy minimizations were carried out in vaccum for six cases of non‐MODIP predicted, three cases of MODIP predicted disulfide‐bonded, helical segments, and five nSS Trx protein derivatives in which intrahelical disulfides had been introduced *in silico*. As mentioned earlier in this article, nSS Trx is a derivative of *E. coli* thioredoxin in which both CYS in the active site are mutated to SER. The nSS Trx derivatives chosen for the energy minimization studies have also been studied experimentally following mutagenesis of nSS Trx (described in a later section). The coordinates of the starting structures for energy minimization were obtained by replacing the coordinates of the appropriate residues in each PDB file with those of cysteines. The coordinates for the modeled cysteines in proteins were obtained using MODIP for MODIP predicted cases and through the SWISS‐PDB mutagenesis tool for non‐MODIP predicted cases. In the case of nSS Trx derivatives, the sulfur atoms of CYS 32 and CYS 35 (2trx) were replaced by oxygen atoms in the coordinates file before mutagenesis by SWISS‐PDB and energy minimization. Energy minimizations were also carried out for the five pairs of proteins listed in Table [V](#tbl5){ref-type="table"}. Prior to minimization of the reduced structure in each pair, a disulfide was introduced corresponding to the oxidized protein structure by the *in silico* mutagenesis tool of SWISS‐PDB.

Following minimization, the bond angles at sulfur atoms and the disulfide bond length converged at values that are normally observed in naturally occurring disulfides for all the cases. However, the torsion angles across the disulfide bridge for the energy minimized structures carrying disulfides introduced either with MODIP or SWISS‐PDB (MODIP predicted cases, non‐MODIP predicted cases, nSS Trx mutants, and four out of five reduced protein structures from Table [V](#tbl5){ref-type="table"}) showed large deviations from those observed for naturally‐occurring intrahelical disulfides (Table SII, Supporting information). However, the oxidized protein structures (from Table [V](#tbl5){ref-type="table"}) on energy minimization converged to structures with torsion angles across disulfide bonds similar to those observed for naturally‐occurring intrahelical disulfides. The nomenclature for the disulfide parameters is indicated in Figure [3](#fig3){ref-type="fig"}. The energy minimization studies did not reveal significant differences between MODIP and non‐MODIP predicted cases except that the α~R~ and positive ϕ regions of the plot are incompatible with intrahelical disulfide formation. These studies in conjunction with the main chain dihedral angle analysis described above suggest that disulfides can potentially be formed at virtually all exposed α‐helix termini except possibly for those with positive ϕ values. However, one caveat from these studies is that energy minimized predicted structures have very different side chain dihedral angle values from naturally‐occurring disulfides. This suggests that the potential energy functions used for disulfide modeling need improvement.

CXXC motifs as an indicator of redox activity/metal binding activity {#sec2-19}
--------------------------------------------------------------------

Most proteins carrying an intrahelical disulfide are either redox active or bind metal ions through the intrahelical CXXC motif. Hence, the presence of an intrahelical CXXC motif indicates potential redox activity or metal binding. In the reduced state, there are several instances of these N‐terminal intrahelical CXXC motifs binding metal ions. There are no instances of oxidized CXXC motifs at helical C‐termini or inside helices where both CYS are in helical conformations. These intrahelical and C‐terminal helical motifs, however, often coordinate metal ions and cofactors such as heme. Non‐helical, non‐disulfide bridged CXXC motifs also have been found to coordinate metal ions and cofactors in several cases. The secondary structure was predicted for proteins with intrahelical CXXC and non‐helical, oxidized CXXC sequences using PSIPRED.[49](#bib49){ref-type="ref"} PSIPRED predictions with at least two out of the four residues of CXXC sequence being helical were considered as a prediction for an intrahelical CXXC motif. All 14 non‐helical CXXC containing proteins (Table [IV](#tbl4){ref-type="table"}) were correctly predicted to be non‐helical. However, only 79 out of 102 known N‐terminal intrahelical CXXC motifs were correctly predicted to be helical. This is consistent with a known prediction accuracy of about 75% for PSIPRED.[49](#bib49){ref-type="ref"}, [50](#bib50){ref-type="ref"} Hence, PSIPRED secondary structure prediction can be used to decide if a CXXC sequence is helical and consequently involved in redox activity or metal binding. Further, if a CXXC motif is predicted to be helical and is known to be disulfide bridged, then the probability of the N‐terminal CYS being the N‐Cap of the helix is high.

Engineered intrahelical disulfides in thioredoxin {#sec2-20}
-------------------------------------------------

To experimentally validate the above analysis, pairs of cysteines were introduced at multiple locations in α‐helices of *E. coli* thioredoxin. Thioredoxin is a 108 amino acid long oxidoreductase.[51](#bib51){ref-type="ref"} It is a monomeric, highly stable protein containing a core β‐sheet flanked by helices. There are four α‐helices and a distorted 3~10~ helix. The α‐helices designated as α1--α4 (as defined in the PDB‐ID 2trx) are from residues 11--17, 32--49, 59--63, and 95--107, respectively. Each of the residues at N‐termini have non‐helical (ϕ, ψ) values of (−89.1°, −6.8°), (−90.2°, 108.7°), (−79.1°, 118.0°), and (−85.2°, 162.9°), respectively, for residues 11, 32, 59, and 95. The residues 11, 32, 59, and 95 are the N‐Cap residues of the helices in thioredoxin. Of the four helices described above, it is already known that α1 is disordered and a disulfide occurs at the N‐terminus of α2 in WT Trx. We therefore, attempted to introduce disulfides at the N‐terminus of helices α3 and α4, respectively. Since analysis of PDB structures showed that glycine and proline are the preferred amino acids at positions 2 and 3 of the CXXC motif, additional mutants were made incorporating these residues. Finally, to study if disulfides could be formed at non N‐Cap helical positions, CYS pairs were also introduced at positions 1,4 in α3 and α4 as well as positions 7,10 in α4. This could theoretically occur if there was a change in the helix start site in the mutant protein. Since our aim was to check if disulfide formation at engineered CXXC sites could be used to probe helix start sites in proteins of unknown structure, it was important to include these positions. Thioredoxin contains two active site cysteines at positions 32 and 35. These were mutated to serines to yield nSS Trx and additional intrahelical pairs of CYS residues were introduced into this mutant background. Following expression and purification from *E. coli*, the redox status of the introduced CYS residues was examined by iodoacetamide labeling. Iodoacetamide will react only with reduced CYS residues, and the resultant acetylated product will result in a mass increase of 57 Da per acetylation. The results are summarized in Table [VII](#tbl7){ref-type="table"}. Iodoacetamide labeling studies confirmed that while N‐Cap‐3 disulfides formed spontaneously, the 1‐4 disulfides did not form until subjected to more oxidizing conditions in the presence of 1,10‐phenanthroline monohydrate.[42](#bib42){ref-type="ref"} This shows that the N‐Cap‐3 positions of a helix are poised to form the disulfide as observed in naturally‐occurring intrahelical disulfides. The absence of spontaneous disulfide formation in the 1--4 positions further reiterates the importance of the N‐terminal CYS residue to be non‐helical for disulfide formation. The mutant with the disulfide in the 7--10 position formed a intermolecular disulfide leading to dimer formation and is described in more detail elsewhere[46](#bib46){ref-type="ref"} and this mutant was not used further in the present work. Mass spectrometry and SDS‐PAGE in the absence of a reducing agent confirmed that engineered cysteines were not involved in the formation of intermolecular disulfides with the exception of the 7--10 mutant (Trx F102C A105C) described above.

###### 

Protein Mass (Da) Determined by ESI‐MS Before and After Iodoacetamide Labeling for the Confirmation of Disulfide Bond Formation

  Protein                                  Expected mass[a](#fn15){ref-type="fn"}   Observed mass   Observed mass[b](#fn16){ref-type="fn"} (Iodoacetamide treated)
  ---------------------------------------- ---------------------------------------- --------------- ----------------------------------------------------------------
  nSS Trx                                  11643.3                                  11642.3         11643.0
  CIDC (59--62)                            11605.3                                  11605.3         11606.5
  CIPC (59--62)                            11587.4                                  11588.7         11587.4
  CGPC (59--62)                            11531.2                                  11531.5         11534.7
  CKGC (95--98)                            11632.4                                  11633.5         11633.8
  CGPC (95--98)                            11601.3                                  11601.3         11603.7
  CDQC (60--63)                            11620.3                                  11622.0         11736.0[c](#fn17){ref-type="fn"}
  CGQC (96--99)                            11606.2                                  11606.8         11722.1[c](#fn17){ref-type="fn"}
  CDQC (60--63)[d](#fn18){ref-type="fn"}   11620.3                                  11619.9         11619.7
  CGQC (96--99)[d](#fn18){ref-type="fn"}   11606.2                                  11606.8         11606.9

Mass of oxidized protein.

Mass observed after denaturation and incubation with iodoacetamide.

An observed mass increase of 116 Da (with respect to the oxidized protein mass).

Disulfide bond formation was observed after copper‐phenanthroline oxidation.

Wiley-Liss, Inc.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

Far UV CD spectroscopy of intrahelical disulfide mutants {#sec2-21}
--------------------------------------------------------

Purified mutants were characterized by far UV‐CD spectroscopy in the wavelength range of 200--250 nm (see Fig. [4](#fig4){ref-type="fig"}). All N‐Cap‐3 mutants and the 1--4 mutant CDQC (60--63) displayed spectra similar to nSS Trx in both oxidized and reduced states indicating that there were no gross structural changes in the structure of the protein. However, the oxidized 1--4 mutant CGQC (96--99) had a drastically altered CD spectrum from that of nSS Trx. The reduction of the disulfide resulted in a spectrum similar to that of nSS Trx indicating that forced intrahelical disulfide formation at a non N‐terminal position can disrupt the protein structure. These observations emphasize the importance of the N‐terminal position with non‐helical (ϕ, ψ) values for intrahelical disulfide formation.

![CD spectra of 10 μ*M* nSS Trx and its intrahelical disulfide mutants in (**A**) oxidized and (**B**) reduced states. All measurements were collected with 10 μ*M* protein in CGH 10 buffer at pH 7.0, 298 K. The spectra for the reduced state were collected in the presence of 0.5 m*M* DTT. All proteins have similar secondary structure except for oxidized CQGC (96--99), which appears to be unfolded.](PROT-78-1228-g005){#fig4}

Effect of engineered intrahelical disulfides on protein stability {#sec2-22}
-----------------------------------------------------------------

To examine the effect of the engineered disulfides on protein stability, nSS Trx, and all mutants were characterized by both isothermal chemical denaturation with GdmCl and DSC. All chemical denaturation melts of proteins were fit using the *m*‐value for nSS Trx chemical denaturation (*m*‐value = −3.5 kcal mol^−1^ *M* ^−1^). Chemical denaturation was reversible for all oxidized mutants with the exception of CGQC (96--99). All mutants except CDQC (60--63) showed reversible thermal melt profiles on DSC. The thermal melt of CDQC (60--63) in the oxidized state could not be studied owing to aggregation of the protein. It was not possible to analyze DSC scans for any of the reduced proteins, carried out in the presence of 1 m*M* DTT. This could be owing to some irreversible changes such as aggregation, non‐2 state melts or proline isomerisations. No stability studies were carried out with the CGQC (96--99) mutant in the oxidized state since it has undergone a drastic structural change.

Formation of engineered intrahelical disulfides led to destabilization of the protein with respect to nSS Trx in all cases. The reduction in stability was confirmed by both, chemical and thermal denaturation studies (Table [VIII](#tbl8){ref-type="table"} and Figs. [5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}) in the oxidized state. All oxidized mutants had lower values of *C* ~m~ and *T* ~m~ relative to nSS Trx. Both chemical and thermal melts were analyzed assuming two‐state denaturation. In all cases, the transitions fit well to a two‐state model. A more rigorous demonstration would involve monitoring chemical denaturation with an independent probe such as tryptophan fluorescence as was done for WT Trx in the oxidized state.[52](#bib52){ref-type="ref"} In the case of reduced thioredoxin, the baselines obtained by monitoring fluorescence in a chemical melt have large slopes. Hence, denaturation of reduced thioredoxin is typically monitored by CD as is done in the present work for nSS Trx. Thus, we have not conclusively shown that denaturation of nSS Trx and its derivatives is two‐state. However, this does not alter any of the principal conclusions derived from the data in Table [VIII](#tbl8){ref-type="table"}, namely that the engineered intrahelical disulfides in nSS Trx are all destabilizing. The extent of destabilization depends on the identity of the residues in the CXXC motif. In addition, forcible formation of a disulfide at non N‐terminal helical positions is highly destabilizing.

![Isothermal chemical denaturation studies on nSS Trx (•) and intrahelical disulfide mutants of nSS Trx \[CIPC (59--62)(o), CIDC (59--62)(▾), CKGC (95--98)(Δ), CGPC (95--98)(▪), CDQC (60--63)(□), and CGQC (96--99)(▿)\] showing the fraction unfolded (*f* ~u~) as a function of denaturant concentration for (**A**) oxidized and (**B**,**C**) reduced proteins at pH 7.0, 298 K. Data were fitted to a two state model with globally fit *m* values of −3.4 kcal mol^−1^ M^−1^ for both oxidized and reduced proteins. Unfolding of the oxidized and reduced proteins was monitored by CD spectroscopy at 298 K at 222 nm. All proteins have reduced stability relative to nSS Trx in both oxidized and reduced states.](PROT-78-1228-g004){#fig5}

![DSC studies on nSS Trx and its intrahelical disulfide mutants in the oxidized state at pH 7.0. DSC scans of baseline subtracted excess heat capacity as a function of temperature for the oxidized proteins show that all mutants are thermally less stable than nSS Trx. Protein identities are indicated in increasing order of *T* ~m~ in the inset. Raw data are shown as open circles and the fitted data are shown as lines in all cases.](PROT-78-1228-g007){#fig6}

###### 

The Stability of nSS Trx and Its Intrahelical Disulfide Mutants Under Oxidized and Reduced Conditions as Measured by Isothermal Denaturation Studies at 25°C, pH 7.0, and DSC Studies

  Protein                                     Δ*G*° (25°C)[a](#fn19){ref-type="fn"} (kcal mol^−1^)   *C* ~m~ (M)^b^   ΔΔ*G*° (25°C)[c](#fn21){ref-type="fn"} (kcal mol^−1^)   Δ*C* ~m~ (M)   *T* ~m~ (°C)^d^   Δ*T* ~m~ (°C)   Δ*H*°(*T* ~m~) (kcal mol^−1^)^e^
  ------------------------------------------- ------------------------------------------------------ ---------------- ------------------------------------------------------- -------------- ----------------- --------------- ----------------------------------
  nSS Trx                                     5.5 ± 0.3                                              1.6              ---                                                     ---            77.4              ---             117.0
  CIDC (59--62)                               4.1 ± 0.1                                              1.2              −1.4                                                    −0.4           62.0              −15.4           52.9
  CIPC (59--62)                               3.5 ± 0.1                                              1.0              −2.0                                                    −0.6           65.6              −11.8           67.1
  CGPC (59--62)[f](#fn22){ref-type="fn"}      ---                                                    ---              ---                                                     ---            ---               ---             ---
  CKGC (95--98)                               3.8 ± 0.1                                              1.1              −1.5                                                    −0.4           66.1              −11.3           67.4
  CGPC (95--98)                               4.3 ± 0.1                                              1.2              −1.2                                                    −0.4           66.2              −11.2           62.0
  CDQC (60--63)[g](#fn23){ref-type="fn"}      1.7 ± 0.1                                              0.5              −3.8                                                    −1.1           ---               ---             ---
  CGQC (96--99)[h](#fn24){ref-type="fn"}      ---                                                    ---              ---                                                     ---            ---               ---             ---
  CIDC (59--62)red[i](#fn25){ref-type="fn"}   4.6 ± 0.1                                              1.3              −0.9                                                    −0.3           ---               ---             ---
  CIPC (59--62)red[i](#fn25){ref-type="fn"}   3.3 ± 0.4                                              1.0              −2.2                                                    −0.6           ---               ---             ---
  CKGC (95--98)red[i](#fn25){ref-type="fn"}   4.3 ± 0.9                                              1.2              −1.2                                                    −0.4           ---               ---             ---
  CGPC (95--98)red[i](#fn25){ref-type="fn"}   3.4 ± 0.1                                              1.0              −2.1                                                    −0.6           ---               ---             ---
  CDQC (60--63)red[i](#fn25){ref-type="fn"}   3.8 ± 0.1                                              1.1              −1.7                                                    −0.5           ---               ---             ---
  CGQC (96--99)red[i](#fn25){ref-type="fn"}   2.9 ± 0.1                                              0.8              −2.6                                                    −0.8           ---               ---             ---

All isothermal melts were fitted with the same *m* value of --3.4 kcal mol^−1^.

^b,d,e^Approximate errors are 0.05*M* for *C* ~m~, 1°C for *T* ~m~, and 5% for Δ*H*°(*T* ~m~).

ΔΔ*G*° = Δ*G*°(mutant)−Δ*G*°(nSS Trx) where Δ*G*° is free energy of unfolding.

Protein CGPC (59--62) was unstable and could not be purified.

CDQC (60--63) could not be characterized by DSC since it precipitated during thermal melt.

CGQC (96--99) underwent drastic structural change on formation of disulfide bond.

All melts in the reduced state were carried out in the presence of 20‐fold molar excess of protein.
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An analysis of residue preferences at positions 2 and 3 of the CXXC motif had suggested that glycine and proline are the preferred substitutions at these positions. However, incorporation of these preferred amino acids also failed to improve protein stability. In the case of CXXC mutants in the 59--62 region, introduction of glycine, proline at positions 60--61 or proline alone at position 61 resulted in significant destabilization of the protein relative to nSS Trx. In contrast, for the 95--98 mutants, the CGPC mutant was less destabilized than the CKGC mutant, which retained the WT residues at positions 1,2 of the CXXC motif (Table [VIII](#tbl8){ref-type="table"}). A comparison of mutant stabilities in the oxidized and reduced states shows that all N‐Cap‐3 mutants had similar stabilities in both the reduced and oxidized states. In one case CGPC (95--98), the mutant was marginally more stable in the oxidized state (Δ*C* ~m~ = 0.2*M*).

In the case of the two 1--4 mutants studied here, both are significantly stabilized in the reduced state relative to the oxidized state. The CDQC (60--63) mutant is conformationally deformed in the oxidized state. The CDQC (60--63) reduced mutant is stabilized by about 2.1 kcal mol^−1^ with respect to the oxidized state. The destabilizing nature of these disulfides could be owing to the non N‐terminal nature of the CXXC motif.

For WT Trx, reduction of the disulfide leads to a large decrease in stability (ΔΔ*G*° = 2.4 kcal mol^−1^ at 298 K).[44](#bib44){ref-type="ref"} Consistent with this, nSS Trx also has lower stability than oxidized WT Trx, but similar stability to reduced Trx. However, the data in Table [VII](#tbl7){ref-type="table"} clearly demonstrate that introduction of disulfides at N‐termini of other helices in thioredoxin does not lead to similar improvements in protein stability. The two contributing factors to the above observation are discussed below.

First, formation of disulfide involves a degree of protein conformational rearrangement, which may have an energetic cost. This is especially true for disulfides at buried positions. Second, the residues that were mutated to cysteines may have been involved in various favorable interactions. In the present case, for example the side chains of N59, S95, and Q98 all form hydrogen bonds to the amide nitrogen atoms of residues D61, Q98, and S95, respectively, in the WT Trx protein. All of these hydrogen bonds would be lost upon mutation of residues N59, S95, and Q98 to CYS.

Activity of thioredoxin with engineered CXXC motifs {#sec2-23}
---------------------------------------------------

Intrahelical CXXC motifs are a characteristic feature of several oxidoreductases and are responsible for their redox activity. Hence, it was of interest to examine if the thioredoxin mutants carrying engineered intrahelical CXXC motifs can display thioredoxin like redox activity. Thioredoxin catalyzes the reduction of insulin by DTT. Upon reduction, the insulin B chain aggregates and this can be monitored by light scattering at 650 nm. All the CXXC mutants (N‐Cap‐3 and 1--4 disulfide mutants) show varying degrees of activity (see Fig. [7](#fig7){ref-type="fig"}). However, all mutants have activities lower than WT Trx. This reduced level of activity is expected since the active site helix of thioredoxin is evolutionarily optimized for redox activity. Further, recent studies have shown that the conserved cis‐proline loop in thioredoxin plays an important role in its substrate specificity and activity.[53](#bib53){ref-type="ref"} Surprisingly, there was no clear correlation between the position of the CXXC motif in the helix with respect to the level of activity. Expectedly, nSS Trx that lacks cysteine residues showed no activity. Control proteins MBP 230C 30C and Trx 20C 73C contain two CYS residues such that the cysteine *C* ^α^ atoms are separated by 35.3 Å and 27.3 Å apart in the structures of WT MBP and WT Trx, respectively. They also showed no activity (Fig. S1, Supporting information). This shows that merely having two free cysteine residues in a protein does not confer redox activity.

![Thioredoxin‐catalyzed reduction of insulin. Insulin aggregation following reduction was monitored by the increase in light scattering at 650 nm. Assay conditions were 0.1*M* phosphate buffer, 2 m*M* EDTA, 0.13 m*M* porcine insulin, 0.33 m*M* DTT, and 10 μ*M* protein. Protein identitites are adjacent to each trace. Incubation mixture without protein served as control.](PROT-78-1228-g001){#fig7}

CONCLUSIONS AND FUTURE DIRECTIONS {#sec1-4}
=================================

The present study clearly demonstrates that intrahelical disulfides can only occur at the N‐terminus of an α‐helix and that the N‐terminal CYS residue must adopt a non‐helical backbone conformation. Experimental studies with *E. coli* thioredoxin showed that disulfides could be introduced at the N‐termini of two different helices. The engineered disulfides did not increase protein stability, probably because the favorable interactions involving the WT residues are lost upon substitution with cysteines. However, the mutants showed redox activity in an insulin reduction assay. It is, therefore, possible to engineer such intrahelical disulfides and such engineered intrahelical disulfides can confer redox activity on a protein. In cases where the three dimensional structure is unknown, such engineered disulfides might also be used to experimentally determine the location of helix start sites. CYS can potentially be replaced by selenocysteine. This suggests the possibility of using engineered diselenide derivatives to obtain phase information by anomalous scattering. In contrast to the commonly used selenomethionine derivatives, such diselenides may be better ordered.
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